Evolution of the Average Target: Amarin Corporation plc

Evolution of the Target Price: Amarin Corporation plc

Changes in Analyst Recommendations: Amarin Corporation plc

96baef1e94a5aa49283a2e562bc9bde.ntlRcAfGj8CFgxNOMWXCC0lvrDFI0Mat31BSt7mapKw.zJU5B0_zx4bO4FQoegmkTScXmkA8n6v5mglkwtjq7ZruujApNpPj8umwRg~8c0357c2f7b7791dcc6790e483a09640
25-10-27 Amarin issues statement supporting FDA's action to revise labeling for fenofibrate drugs reinforcing a lack of cardiovascular benefit RE
25-06-25 RBC Ups Recordati's Price Target on Cardiovascular Drug European Licensing Deal MT
23-10-25 Jefferies Downgrades Amarin to Hold From Buy, Cuts Price Target to $1 From $3 MT
23-07-19 Northland Adjusts Price Target on Amarin to $1.25 From $2, Maintains Market Perform Rating MT
23-01-06 Jefferies Upgrades Amarin to Buy From Hold, Adjusts Price Target to $3 From $1.30 MT
22-10-19 SVB Securities Adjusts Amarin's Price Target to $2 From $3, Maintains Market Perform Rating MT
22-05-06 JPMorgan Downgrades Amarin to Underweight From Neutral MT
22-05-05 HC Wainwright Lowers Amarin to Neutral From Buy, Price Target to $3 From $10 MT
22-05-05 SVB Leerink Downgrades Amarin to Market Perform From Outperform, Adjusts Price Target to $3 From $10 MT
22-05-05 Northland Downgrades Amarin to Market Perform From Outperform, Adjusts Price Target to $2 From $9 MT
22-02-16 SVB Leerink Adjusts Amarin's Price Target to $10 from $11, Maintains Outperform Rating MT
22-01-31 SVB Leerink Adjusts Amarin's Price Target to $11 from $12, Keeps Outperform Rating MT
21-05-12 Amarin : Goldman Sachs Downgrades Amarin to Sell From Neutral, Adjusts Price Target to $5 From $6 MT
21-02-01 Amarin : SVB Leerink Adjusts Price Target on Amarin to $16 From $12, Maintains Outperform Rating MT
20-12-23 Amarin : Goldman Sachs Adjusts Amarin's Price Target to $6 From $8, Maintains Neutral Rating MT
20-12-07 Amarin : Citigroup Adjusts Amarin's Price Target to $7 from $12, Maintains Buy Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- -9.71%
+19.12%
+11.09%
+64.75%
+18.05%
+13.05%
+6.66%
+26.26%
-5.63%
+25.87%
Average +16.95%
Weighted average by Cap. +19.75%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
2
Last Close Price
13.70USD
Average target price
12.50USD
Spread / Average Target
-8.76%
High Price Target
13.00USD
Spread / Highest target
-5.11%
Low Price Target
12.00USD
Spread / Lowest Target
-12.41%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
  1. Stock Market
  2. Stocks
  3. AMRN Stock
  4. Consensus Amarin Corporation plc